Fredrickson, D.S., Levy, R.T.Lees, R.S.: Fat transport in lipoproteins: An integrated approach to mechnisms and disorders. N. Engl. J. Med.276: 34-44, 94-103, 148-156, 215-225, 273-281, 1967.
2.
Allen, E.V., Barker, N.W., Hines, E.A.: Peripheral Vascular Diseases pp. 197-199. Fourth Edition. W. B. Saunders Company, Philadelphia, 1972.
3.
Dry, T.J., Hines, E.A., Jr.: The role of diabetes in the development of degenerative vascular disease: With special reference to the incidence of retinitis and peripheral neuritis. Ann. Intern. Med., 14: 1893-1902, 1941.
4.
Bell, E.T.: Incidence of gangrene of extremities in nondiabetic and in diabetic persons . Arch. Pathol., 49: 469-473, 1950.
5.
Schadt, D.C. , Hines, E.A., Jr., Juergens , J.I., et al.: Chronic atherosclerotic occlusion of the femoral artery. J.A.M.A.175: 937, 1961 .
6.
Conrad, M.C. : Large and small artery occlusion in diabetics and nondiabetics with severe vascular disease. Circulation , 36: 83-91, 1967.
7.
Moritz, A.R. , Oldt, M.R.: Arteriosclerosis in hypertensive and nonhypertensive individuals. Am. J. Pathol., 13: 679, 1937.
8.
Wilkins, R.H. , Roberts, J.C., Jr., Moses, C.: Autopsy studies in arteriosclerosis. III. Distribution and severity in atherosclerosis in the presence of obesity, hypertension, nephrosclerosis and rheumatic heart disease. Circulation, 20: 527-536, 1959.
9.
Juergens, J.L. , Barker, N.W., Hines, E.A., Jr.: Arteriosclerosis obliterans: Review of 520 cases with special reference to pathogenic and prognostic factors. Circulation, 21: 188, 1960.
10.
Coffman, J.D. , Javett, S.L.: Blood flow to the human calf during tobacco smoking. Circulation, 28: 932, 1963.
11.
Kannel, W.B. , Shurtleff, D.: Cigarettes and development of intermittent claudication: Framing-ham study. Geriatrics, 28: 61-68, 1973.
12.
Wray, R., DePalma, R.G., Hubay, C.H.: Late occlusion of aortofemoral bypass grafts: Influence of cigarette smoking . Surgery, 70: 969-973, 1971.
13.
Gillespie, J.A.: The case against vasodilator drugs in occlusive vascular disease of the legs. Lancet, 2: 995-997, 1959.
14.
Coffman, J.D. , Mannick, J.A.: Failure of vasodilator drugs in arteriosclerosis obliterans. Ann. Intern. Med., 76: 35-39, 1972.
15.
Shimamoto, T., Atsumi, T., Yamashita, S., et al.: Clinical pharmacologic evaluation of the antiatherosclerotic agent, pyridinolcarbamate. A double-blind crossover trial in the treatment of atherosclerosis obliterans. Am. Heart J., 79: 5, 1970.
16.
Walton, K.W., Craig, G.M., Prior, P., et al.: Double-blind crossover clinical trial of pyridinolcarbamate in peripheral arterial disease (arteriosclerosis obliterans). Br. Heart J., 35: 211-219, 1973.
17.
Skinner, J.S. , Strandness, D.E., Jr: Exercise and intermittent claudication. II. Effect of physical training. Circulation, 36: 23, 1967.
18.
Larsen, O.A., Lassen, N.A.: Effect of daily muscular exercise in patients with intermittent claudication . Lancet, 2: 1093, 1966.
19.
Wisham, L.H., Abramson, A.S., Ebel, A.: Value of exercise in peripheral arterial disease. J.A.M.A. , Vol. 153: 10, 1953.
20.
Forno, C., Montgomery, H., Horwitz, O.: Influence of an oscillating bed on cutaneous temperature and oxygen tension of ischemic toes. Circulation, 17: 277, 1958.
Lassen, N.A. , Larsen, O.A., Sorenson, A.W.S.: Conservative treatment of gangrene using mineralocorticoid induced moderate hypertension. LancetI: 606-609, 1968.
23.
Tillgren, C. : Obliterative arterial disease of the lower limbs. IV. Evaluation of long-term anticoagulant therapy. Acta. Med. Scand., 178: 203-219, 1965.
Verstraete, M., Vermylen, J., Amery, A., et al.: Thrombolytic therapy with streptokinase using a standard dose scheme. Br. Med. J., 1: 454, 1966.
26.
Poliwoda, H. , Alexander, K., Buhl, V., et al.: Treatment of chronic arterial occlusions with streptokinase. N. Engl. J. Med., 280: 689, 1969 .
27.
Hvidt, V., Dohn, K., Lund, J. et al.: Ugeskr. Laeger, 127: 1116, 1965.
28.
Hentzer, E. , Madsen, P.C.: Testosterone in the treatment of arterial insufficiency of the lower limbs. Scand. J. Clin. Lab. Invest. (Suppl), 93: 198206, 1967.
